BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Smruthi Organics Ltd. Share Price

NSE
BSE

BSE : 540686

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

High

Price Summary

Previous Close ₹118.25
Day's Range ₹118.25 - ₹120.00
Open ₹119.45
52 Week Range ₹95.00 - ₹164.00
Volume 1,190
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 1.41
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 1.26
Price/Earning (TTM) 39.93
TTM EPS (₹) 2.99
P/E Ratio 35.42
Book Value(₹) 1.86
PAT Margin (%) 2.81
Face Value (₹) 10.00
ROCE(%) 7.98

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 380.94 1260.08
Expenses N/A N/A
PBT 27.34 49.0
Operating profit 0.0 0.0
Net profit 22.3 35.63

Shareholding Pattern

Promoters (% Holding)

64.73%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

35.27%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.00%

About Smruthi Organics Ltd.

Founded 1989
Managing Director Purushotham Eaga

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,41,789.55 1,841.20 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 1,79,450.12 6,746.70 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,54,733.87 4,450.00 3,102.00 - 3,102.00
Apollo Hospitals Enterprise Ltd. 1,20,848.85 8,264.00 6,696.50 - 6,696.50
Cipla Ltd. 1,14,182.61 1,417.05 1,165.70 - 1,165.70
Dr. Reddy's Laboratories Ltd. 1,11,184.65 1,329.35 1,148.40 - 1,148.40
Zydus Lifesciences Ltd. 1,07,973.94 1,078.95 835.50 - 835.50
Lupin Ltd. 1,04,613.28 2,263.85 1,836.80 - 1,836.80
Mankind Pharma Ltd. 1,01,443.53 2,418.55 1,909.70 - 1,909.70
Max Healthcare Institute Ltd. 97,382.77 993.00 903.00 - 903.00
no-content No Records Found

Latest News

Mar
9
2026
EQUITY Posted on Mar 9th 2026

Smruthi Organics informs about receipt of CEP certificate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Smruthi Organics has informed that the Company has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM), Europe for its product Amlodipine Besilate. The CEP certifies that the quality of the substance complies with the requirements of the European Pharmacopoeia and enables the Company to supply this product to pharmaceutical manufacturers in European markets and other regions that recognize the CEP certification. This milestone strengthens the Company’s regulatory portfolio and enhances opportunities to expand its presence in regulated markets.

The above information is a part of company’s filings submitted to BSE.

Read More
Mar
4
2026
EQUITY Posted on Mar 4th 2026

Smruthi Orgnics informs about receipt of attestation of inspection

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Smruthi Orgnics has informed that the company has received an ‘Attestation of Inspection’ from the European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, following the inspection conducted at its flagship API manufacturing facility, Unit II, Solapur, Maharashtra from 27 August 2025 to 29 August 2025. The attestation confirms compliance with the applicable European Good Manufacturing Practice (EU GMP) requirements under the CEP framework in respect of Amlodipine Besilate. A detailed disclosure in this regard is enclosed.

The above information is a part of company’s filings submitted to BSE.

Read More
May
26
2026
EQUITY Posted on May 26th 2026

Blue Jet Healthcare informs about press release

Blue Jet Healthcare has informed that it enclosed newspaper advertisement published in Financial Express and Navshakti today, on Tuesday, May 26, 2026 containing extracts of Audited Standalone Financial Results for the quarter and financial year ended March 31, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
May
26
2026
EQUITY Posted on May 26th 2026

Blue Jet Healthcare informs about press release

Blue Jet Healthcare has informed that it enclosed newspaper advertisement published in Financial Express and Navshakti today, on Tuesday, May 26, 2026 containing extracts of Audited Standalone Financial Results for the quarter and financial year ended March 31, 2026
The above information is a part of company’s filings submitted to BSE.
Read More
May
26
2026
EQUITY Posted on May 26th 2026

GPT Healthcare informs about compliance report

GPT Healthcare has informed that it enclosed the Annual Secretarial Compliance Report issued by Ashok Kumar Daga, Company Secretary in Practice for the year ended March 31, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Smruthi Organics Ltd. ?

The current share price of Smruthi Organics Ltd. is ₹118.25 as of 2026-05-26.

The market capitalisation of Smruthi Organics Ltd. is ₹136.73 as of 2026-05-25.

The 1-year return of Smruthi Organics Ltd. is -17.55% as of 2025-05-23.

The P/E ratio of Smruthi Organics Ltd. is 35.42 as of 2026-05-26.

The 52-week high and low of Smruthi Organics Ltd. are ₹164.00 and ₹95.00, respectively, as of 2026-05-26.

The dividend yield of Smruthi Organics Ltd. is 1.2558% as of2026-05-25.

You can buy Smruthi Organics Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Smruthi Organics Ltd. is Purushotham Eaga.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore